ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 35

Rheumatoid Arthritis As a Risk Factor for Cardiovascular Events Following Hospitalized Pneumonia; A Population-Based Cohort Study

Mette Holland-Fischer1, Ulrik Tarp2, Reimar W. Thomsen3 and Mette Nørgaard3, 1Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark, 2Department of Rheumatology, Aarhus University Hospital, AArhus, Denmark, 3Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, infection and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Epidemiology and Public Health Poster I: Comorbidities and Outcomes of Systemic Inflammatory Diseases

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

 

Background/Purpose: Cardiovascular disease is a major cause of morbidity and mortality in patients with Rheumatoid Arthritis (RA). Patients with RA do also have an increased risk of infections. Previous studies suggest that recent infection may trigger myocardial infarction and stroke, and this mechanism may be particularly important in patients with underlying low-grade inflammation such as RA.  Our objective was to examine whether RA-patients have increased risk of cardiovascular events (CVE) following hospitalized pneumonia compared to patients with pneumonia without RA.

Methods: We conducted this population-based cohort study of adults with a first-time hospitalization with pneumonia between 1997 and 2011 in Northern Denmark. Information on RA, comorbidity, pneumonia and CVE was obtained from medical databases. Comorbidity data included the 19 conditions in the Charlson Index, alcoholism and previous diagnosis of CVE. We defined CVE as stroke or acute myocardial infarction. Data on mortality was ascertained from the Danish Civil Registration System. Cox regression was used to compute Hazard Ratios (HR) for CVE following hospitalization comparing patients with and without RA, controlling for sex, age, level of comorbidity, prior CVE, alcoholism, and antibiotic therapy before admission.

Results: A total of 75,087 patients were hospitalized with pneumonia. Among them 1677 (2.2%) had RA. All-cause mortality after 30 or 90 days did not differ between RA- and non-RA-patients with crude 30- and 90-day MRRs of 0.98 (95% CI: 0.87-1.11) and 0.99 (95% CI: 0.89-1.10) and adjusted MRRs of 0.99 (95% CI: 0.87-1.12) and 0.98 (95% CI: 0.88-1.09), respectively (table 1). A larger proportion of the RA-patients had prior CVE 18.1% (95% CI: 16.3-20.0) vs non-RA-patients 15.3% (95% CI: 15.1-15.6). Overall, we found no substantially higher risk of CVE following pneumonia among RA patients compared with non-RA patients (table 2). However, 8 to 30 days after pneumonia CVE risk tended to be increased in RA patients, with corresponding crude and adjusted HRs for CVE of 1.41 (95%CI: 0.94-2.12) and 1.32 (95%CI: 0.88-1.98) (table 2).

Conclusion: A larger proportion of RA patients with a first time hospitalization with pneumonia had prior CVE compared to pneumonia patients without RA. The risk of new CVE 8 to 30 days after pneumonia admission tended to be increased in RA patients.

Table 1 Characteristics of 75087 patients hospitalized for pneumonia from 1997 to 2011 in Northern Denmark

 

Rheumatoid Arthritis

No Rheumatoid Arthritis

N

1677 (2.2%)

73410 (97.8%)

Age (years), mean

72.2

69.2

Sex*

 

 

Women

1099 (65.5%)

34306 (46.7%)

Men

578 (34.5%)

39104 (53.3%)

Comorbidity index*

(Charlson index score)

 

 

Low (0)

552 (32.9 )

 30829 (42.0%)

Medium (1-2)

744 (44.4%)

28335 (38.6%)

High (≥3)

381 (22.7%)

14246 (19.4%)

Prior cardiovascular event*

303 (18.1%)

11235 (15.3%)

Systemic antibiotic therapy* before admission

555 (33.1%)

21890 (29.8%)

30-day mortality*

242 (14.4%)

10773 (14.7%)

90-day mortality*

357 (21.3%)

15759 (21.5%)

Crude 30-day MRR

0.98 (CI:0.87-1.11)

Crude 90-day MRR

0.99 (CI:0.89-1.10)

Adjusted 30-day MRR

0.99 (CI:0.87-1.12)

Adjusted 90-day MRR

0.98 (CI:0.88-1.09)

*Data presented as number of patients and proportion (%)

 

 

 

Table2 CVE following hospitalized pneumonia

 

RA

Non-RA

Crude HR

Adjusted HR^

N

1677

73410

 

 

Patients with CVE on or 1-7 days after admission with pneumonia

105 (6.3%)*

4917 (6.7%)

1.04

(95%CI:0.86-1.26)

 1.01

(95%CI:0.84-1.23)

Patients with CVE 8-30 days after admission with pneumonia

24 (1.4%)*

853 (1.2%)*

1.41

 (95%CI:0.94-2.12)

1.32

(95%CI:0.88-1.98)

Patients with CVE 31-90 days after admission with pneumonia

17 (1.0%)*

832 (1.1%)*

1.00

 (95% CI:0.62-1.62)

0.94

 (95% CI:0.58-1.52)

Patients with CVE 91-180 days after admission with pneumonia

13 (0.8%)*

645 (0.9%)*

0.98

(95% CI:0.57-1.70)

0.92

(95% CI:0.53-1.60)

*Data presented as number of patients and proportion (%)

^ Adjusted for sex, age, level of comorbidity, prior cardiovascular events, alcoholism and antibiotics before admission

CVE: cardiovascular event

 


Disclosure: M. Holland-Fischer, None; U. Tarp, None; R. W. Thomsen, None; M. Nørgaard, None.

To cite this abstract in AMA style:

Holland-Fischer M, Tarp U, Thomsen RW, Nørgaard M. Rheumatoid Arthritis As a Risk Factor for Cardiovascular Events Following Hospitalized Pneumonia; A Population-Based Cohort Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-as-a-risk-factor-for-cardiovascular-events-following-hospitalized-pneumonia-a-population-based-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-as-a-risk-factor-for-cardiovascular-events-following-hospitalized-pneumonia-a-population-based-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology